Failed socialist presidential candidate Bernie Sanders is hastily tweeting about a COVID-19-fighting company. He's clearly upset that this leading biotech could be handsomely rewarded if it successfully creates the world's first coronavirus treatment. And it just released data that shows its drug reduced deaths by 62% in a trial, according to Barron's. That's great news, right? Well, Bernie is huffing and puffing. He says the government should now "take control of the patent" and provide the drug to all who need it at no charge. That's not how business works here in America, I'm sorry. While I agree that the drug should be available to everyone who needs it... This company has already "invested $1 billion in manufacturing the drug and donated the first round of supplies to governments," according to The Wall Street Journal. Look, there no indication that the government is going to step in and effectively steal this company's patent. ZERO. So let's stop for a minute and think about this... If Bernie thinks this company will see a dramatic increase in revenue with a successful drug... Doesn't that typically lead to a rise in the stock? As I explain here, you bet it does. In fact, I believe this biotech's stock will enjoy one of the greatest runs over the course of this year... and beyond. Get the scoop on the drug-creating company paving the way to the COVID-19 cure. Sincerely, Marc | 
No comments:
Post a Comment